Wunderlich Capital Managemnt Bristol Myers Squibb CO Transaction History

Wunderlich Capital Managemnt

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$53.63 - $62.52 $654,554 - $763,056	-12,205 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$59.17 - $69.31 $722,169 - $845,928	12,205 New	12,205 $722,000
Q2 2019 Aug 14, 2019	SELL	$44.62 - $49.34 $1.4 Million - $1.54 Million	-31,301 Closed	0 $0
Q1 2019 May 16, 2019	BUY	$45.12 - $53.8 $30,185 - $35,992	669 Added 2.18%	31,301 $1.49 Million
Q4 2018 Feb 14, 2019	SELL	$48.76 - $63.23 $4,973 - $6,449	-102 Reduced 0.33%	30,632 $1.59 Million
Q3 2018 Nov 15, 2018	SELL	$55.19 - $62.25 $85,323 - $96,238	-1,546 Reduced 4.79%	30,734 $1.91 Million
Q2 2018 Aug 14, 2018	BUY	$50.53 - $62.98 $1.63 Million - $2.03 Million	32,280 New	32,280 $1.79 Million

2,532

1.47B

31.6M

35M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $124B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Wunderlich Capital Managemnt, based on Form 13F filings with the SEC.

Stay updated on Wunderlich Capital Managemnt with notifications on news.